These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26024909)

  • 1. The Addition of Intravenous Metronidazole to Oral Vancomycin is Associated With Improved Mortality in Critically Ill Patients With Clostridium difficile Infection.
    Rokas KE; Johnson JW; Beardsley JR; Ohl CA; Luther VP; Williamson JC
    Clin Infect Dis; 2015 Sep; 61(6):934-41. PubMed ID: 26024909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial Commentary: Critically Ill Patients With Clostridium difficile Infection: Are 2 Antibiotics Better Than One?
    Wilcox MH
    Clin Infect Dis; 2015 Sep; 61(6):942-4. PubMed ID: 26024908
    [No Abstract]   [Full Text] [Related]  

  • 3. A real-world evaluation of oral vancomycin for severe Clostridium difficile infection: implications for antibiotic stewardship programs.
    Le F; Arora V; Shah DN; Salazar M; Palmer HR; Garey KW
    Pharmacotherapy; 2012 Feb; 32(2):129-34. PubMed ID: 22392421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection.
    Vega AD; Heil EL; Blackman AL; Banoub M; Kristie Johnson J; Leekha S; Claeys KC
    Pharmacotherapy; 2020 May; 40(5):398-407. PubMed ID: 32246501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of treatment outcomes with vancomycin alone versus combination therapy in severe Clostridium difficile infection.
    Bass SN; Bauer SR; Neuner EA; Lam SW
    J Hosp Infect; 2013 Sep; 85(1):22-7. PubMed ID: 23876778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin and environmental contamination with vancomycin-resistant Enterococci in patients receiving oral metronidazole or oral vancomycin treatment for Clostridium difficile-associated disease.
    Sethi AK; Al-Nassir WN; Nerandzic MM; Donskey CJ
    Infect Control Hosp Epidemiol; 2009 Jan; 30(1):13-7. PubMed ID: 19046063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies.
    Parmar SR; Bhatt V; Yang J; Zhang Q; Schuster M
    J Oncol Pharm Pract; 2014 Jun; 20(3):172-82. PubMed ID: 23804627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Clostridium difficile infection in a French university hospital.
    Khanafer N; Blais L; Barbut F; Hirschel B; Vanhems P
    Scand J Gastroenterol; 2015; 50(10):1253-60. PubMed ID: 25877477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of clinical and microbiological response to treatment of Clostridium difficile-associated disease with metronidazole and vancomycin.
    Al-Nassir WN; Sethi AK; Nerandzic MM; Bobulsky GS; Jump RL; Donskey CJ
    Clin Infect Dis; 2008 Jul; 47(1):56-62. PubMed ID: 18491964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Uncertain Benefits of Combination Therapy for Clostridium difficile Infection.
    Young BE; Ochi H; Marimuthu K
    Clin Infect Dis; 2016 Mar; 62(6):809-10. PubMed ID: 26703863
    [No Abstract]   [Full Text] [Related]  

  • 11. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.
    Zar FA; Bakkanagari SR; Moorthi KM; Davis MB
    Clin Infect Dis; 2007 Aug; 45(3):302-7. PubMed ID: 17599306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vancomycin for the treatment of Clostridium difficile Infection: for whom is this expensive bullet really magic?
    Pepin J
    Clin Infect Dis; 2008 May; 46(10):1493-8. PubMed ID: 18419481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective observational study comparing three different treatment regimes in patients with Clostridium difficile infection.
    Wenisch JM; Schmid D; Kuo HW; Allerberger F; Michl V; Tesik P; Tucek G; Laferl H; Wenisch C
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1974-8. PubMed ID: 22252830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Vancomycin Monotherapy Versus Combination Therapy in Solid Organ Transplant Recipients With Uncomplicated Clostridium difficile Infection: A Retrospective Cohort Study.
    Korayem GB; Eljaaly K; Matthias KR; Zangeneh TT
    Transplant Proc; 2018; 50(1):137-141. PubMed ID: 29407296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial therapy affects duration of diarrhoea in critically ill patients with Clostridioides difficile infection (CDI).
    Manthey CF; Dranova D; Christner M; Drolz A; Kluge S; Lohse AW; Fuhrmann V
    Crit Care; 2019 Dec; 23(1):399. PubMed ID: 31815650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.
    Venugopal AA; Riederer K; Patel SM; Szpunar S; Jahamy H; Valenti S; Shemes SP; Khatib R; Johnson LB
    Scand J Infect Dis; 2012 Apr; 44(4):243-9. PubMed ID: 22077148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The efficacy of intracolonic vancomycin for severe Clostridium difficile colitis: a case series.
    Akamine CM; Ing MB; Jackson CS; Loo LK
    BMC Infect Dis; 2016 Jul; 16():316. PubMed ID: 27388627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evolution of urban C. difficile infection (CDI): CDI in 2009-2011 is less severe and has better outcomes than CDI in 2006-2008.
    Feuerstadt P; Das R; Brandt LJ
    Am J Gastroenterol; 2014 Aug; 109(8):1265-76. PubMed ID: 25001255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of continued antibacterial therapy after diagnosis of hospital-onset Clostridium difficile infection: implications for antimicrobial stewardship.
    Harpe SE; Inocencio TJ; Pakyz AL; Oinonen MJ; Polk RE
    Pharmacotherapy; 2012 Aug; 32(8):744-54. PubMed ID: 23307522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clostridium difficile in visceral surgery].
    Herzog T; Deleites C; Belyaev O; Chromik AM; Uhl W
    Chirurg; 2015 Aug; 86(8):781-6. PubMed ID: 25432576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.